| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EURHEARTJ/EHV575 |
| P698 | PubMed publication ID | 26518245 |
| P50 | author | Gisela Teixido-Tura | Q41640973 |
| V Sánchez | Q73027800 | ||
| P2093 | author name string | David García-Dorado | |
| Arturo Evangelista | |||
| Laura Gutiérrez | |||
| Ignacio Ferreira-González | |||
| José Rodríguez-Palomares | |||
| Alberto Forteza | |||
| Jorge Centeno | |||
| José Cortina | |||
| Paz Sanz | |||
| Teresa Gracia | |||
| Juan Jose Rufilanchas | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Marfan syndrome | Q208562 |
| losartan | Q410074 | ||
| P304 | page(s) | 978-985 | |
| P577 | publication date | 2015-10-29 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial | |
| P478 | volume | 37 |
| Q26744537 | A Case Based Approach to Clinical Genetics of Thoracic Aortic Aneurysm/Dissection |
| Q39094762 | Aetiology and management of hereditary aortopathy |
| Q92554009 | Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation |
| Q55266983 | Angiotensin, transforming growth factor β and aortic dilatation in Marfan syndrome: Of mice and humans. |
| Q47645094 | Beta-blockers for preventing aortic dissection in Marfan syndrome. |
| Q92218873 | Cardiovascular Management of Adults with Marfan Syndrome |
| Q48337723 | Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation |
| Q47751472 | Crossing Bridges between Extra- and Intra-Cellular Events in Thoracic Aortic Aneurysms. |
| Q89449345 | Diagnostic approach and management of genetic aortopathies |
| Q91963506 | Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients |
| Q91969017 | Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial |
| Q48372776 | Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. |
| Q91577868 | Pharmacologic Management of Aneurysms |
| Q39694748 | Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model |
| Q42341364 | Strategies to prevent aortic complications in Marfan syndrome |
| Q90420336 | TGF-β Signaling-Related Genes and Thoracic Aortic Aneurysms and Dissections |
| Q92377672 | The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) |
| Q40952704 | Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models |
| Q64236742 | Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections |
| Q64039452 | Unreliable Estimation of Aortic Pulse Wave Velocity Provided by the Mobil-O-Graph Algorithm-Based System in Marfan Syndrome |
Search more.